Since 2015, we have developed a comprehensive portfolio of diabetes treatment products, including glargine, lispro, and aspart insulin injections, as well as insulin delivery devices and needles. Today, our established global business network spans over 19 countries and regions across the Americas, Europe, Eurasia, Asia-Pacific, and Africa.
Partner with Us: Sterile Contract Chemistry Industry
Manufacturing Medical Device Medicines & Investigational New Drugs
